Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Frontiers in Chemistry
|
August 1, 2020
Rapid Detection of <i>Bifidobacterium bifidum</i> in Feces Sample by Highly Sensitive Quartz Crystal Microbalance Immunosensor
Kaijian Hou, Pingsen Zhao, Yongru Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 20, 2025
Metabolomics and lipidomics predictor of survival in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor and immune checkpoint inhibitor combination therapy
Shaoxing Guan, Guosheng Yuan, Tu Xian, et al.
International Journal of Surgery (London, England)
|
June 20, 2025
Comparison of the efficacy and safety of TACE-HAIC-MTTs-ICIs and TACE-MTTs-ICIs in the hepatocellular carcinoma: a prognostic analysis based on the dynamic changes of serum AFP
Wenli Li, Mingjian Lu, Guosheng Yuan, et al.
Liver Cancer
|
June 26, 2025
Camrelizumab Combined with Lenvatinib and RALOX-Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma (Cal Era): A Prospective, Single-Arm, Phase II Trial
Mengya Zang, Qi Li, Xiaoyun Hu, et al.
Critical Reviews in Food Science and Nutrition
|
September 24, 2021
The effect of guar gum consumption on the lipid profile in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Jilin Li, Rongping Chen, Yongru Chen, et al.
Heliyon
|
October 14, 2024
Cadonilimab (PD-1/CTLA-4) in combination with lenvatinib in unresectable hepatocellular carcinoma (uHCC): A retrospective real-world study
Guosheng Yuan, Yongru Chen, Peilin Zhu, et al.
Academic Radiology
|
January 13, 2026
Outcomes of RALOX-HAIC-based Combination Therapy for Unresectable Hepatocellular Carcinoma with Radiomics-Powered Prediction
Peilin Zhu, Zhanzhou Lin, Zixi Liang, et al.
Frontiers in Pharmacology
|
March 22, 2024
Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on "time in range" in patients with type 2 diabetes
Yongru Chen, Jingxian Chen, Shuo Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 13, 2025
Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma
Rong Li, Wenli Li, Qing Yang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Frontiers in Chemistry
|
August 1, 2020
Rapid Detection of <i>Bifidobacterium bifidum</i> in Feces Sample by Highly Sensitive Quartz Crystal Microbalance Immunosensor
Kaijian Hou, Pingsen Zhao, Yongru Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 20, 2025
Metabolomics and lipidomics predictor of survival in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor and immune checkpoint inhibitor combination therapy
Shaoxing Guan, Guosheng Yuan, Tu Xian, et al.
International Journal of Surgery (London, England)
|
June 20, 2025
Comparison of the efficacy and safety of TACE-HAIC-MTTs-ICIs and TACE-MTTs-ICIs in the hepatocellular carcinoma: a prognostic analysis based on the dynamic changes of serum AFP
Wenli Li, Mingjian Lu, Guosheng Yuan, et al.
Liver Cancer
|
June 26, 2025
Camrelizumab Combined with Lenvatinib and RALOX-Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma (Cal Era): A Prospective, Single-Arm, Phase II Trial
Mengya Zang, Qi Li, Xiaoyun Hu, et al.
Critical Reviews in Food Science and Nutrition
|
September 24, 2021
The effect of guar gum consumption on the lipid profile in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Jilin Li, Rongping Chen, Yongru Chen, et al.
Heliyon
|
October 14, 2024
Cadonilimab (PD-1/CTLA-4) in combination with lenvatinib in unresectable hepatocellular carcinoma (uHCC): A retrospective real-world study
Guosheng Yuan, Yongru Chen, Peilin Zhu, et al.
Academic Radiology
|
January 13, 2026
Outcomes of RALOX-HAIC-based Combination Therapy for Unresectable Hepatocellular Carcinoma with Radiomics-Powered Prediction
Peilin Zhu, Zhanzhou Lin, Zixi Liang, et al.
Frontiers in Pharmacology
|
March 22, 2024
Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on "time in range" in patients with type 2 diabetes
Yongru Chen, Jingxian Chen, Shuo Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 13, 2025
Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma
Rong Li, Wenli Li, Qing Yang, et al.
Page
of 2